[1] Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature,2011,474:307-317.
[2] 翟慧勤,范红,寻琳婷.轻微肝性脑病的研究进展.胃肠病学和肝病学杂志,2012,21,1158-1159.
[3] Dhiman RK,Saraswat VA,Sharma BK, et al.Minimal hepatic encephalopathy:consensus statement of a working part of the lndian National Association for Study of the Liver. J Gastroenterol Hepatol, 2010, 25:1029-1041.
[4] 中华医学会肝病学分会,中华医学会感染病学分会. 慢性乙型肝炎防治指南(2010年版).肝脏,2011,16:4-6.
[5] Wang JY, Zhang NP, Chi BR, et al. Prevalence of minimal hepatic encephalopathy and quality of life evaluations in hospitalized cirrhotic patients in China. World J Gastroenterol, 2013, 19:4984-4991.
[6] 何庆华,彭承琳,吴宝明,王禾.基于视觉诱发电位的脑机接口实验研究.生物医学工程学杂志,2004,21:93-96.
[7] 刘厚钎,石虹.肝性脑病发病机制的新进展.现代消化及介入治疗,2009, 14:92-94.
[8] 石秀红,王月,希尔娜依·阿不都黑力力,等.肝硬化患者轻微肝性脑病临床相关危险因素分析.实用肝脏病杂志,2012,15:542.
[9] Dhiman RK, Cliawla YK. Minimal liepatic enceplialopatliy. Indian J Gastroentero1,2009,28:5-16.
[10] Shawcross DL, Shabbir SS, Taylor NJ, et al. Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology,2010,51:1062-1069.
[11] Riordan SM, Williams R. Cut flora and hepatic encephalopathy in pabents with cirrhosis. N Engl Med, 2010,362:1140-1142.
[12] Pande C, Kumar A, Sarin SK. Small-intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease. Aliment Pharmacol Ther,2009, 29:1273-1281.
[13] Bass NM, Mullen KD, Sanyal A, et al. Rifaximin treatment in hepatic enceplialopatliy. N Engl Med,2010,362:1071-1081.
[14] 肝性脑病诊断治疗专家委员会.肝性脑病诊断治疗专家共识.中华实验和临床感染病杂志(电子版),2009,3:449-473. |
